Infectious Disease

Explore Related Topics

Active Projects: 97

Project Investigator All Topics Start date End date
PREDICT-2 Dean Jamison, PhD Zoonosis, Emerging Disease, and Drug Resistance, Risk Reduction and Prevention
TO#2 Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) - International Sites Edward Murphy, MD, MPH HIV/AIDS, Transfusion Medicine
Simcere Surpi eval project Charles Chiu, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Sustainable East Africa Research in Community Health (SEARCH) Diane Havlir, MD HIV/AIDS, Infectious Disease, Noncommunicable and/or Chronic Disease, Health Economics and Effectiveness, Access or Barriers to Care
Resistance of Malaria Parasites to Artemisinin-Based Therapies Philip J. Rosenthal, MD Zoonosis, Emerging Disease, and Drug Resistance, Malaria
Novel Therapeutics for Treatment of River Blindness and Lymphatic Filariasis Judy Sakanari, PhD Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
A Collaborative Approach to the Design of a Genetically-Stable Oral Polio Vaccine (OPV-2) Raul Andino-Pavlovsky, PhD Infectious Disease, Drug and Diagnostics Development
GINI: Gardasil Immunogenicity with Needle-free Injection-Safety and Immunogenicity of Gardasil using IM and ID needle-free injection delivery Joel Palefsky, MD Sexually Transmitted Infections (STIs), Cancer/Oncology
Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25mg QD versus Tenofovir Disoproxil Fumarate (TDF) 300mg QD for the Treatment of HBeAg-Negative, Chronic Hepatitis B Mandana Khalili, MD Infectious Disease
Leveraging mosquito antiviral immunity to detect viral infections: Towards a scalable field-based approach for predicting arbovirus epidemics Raul Andino-Pavlovsky, PhD Zoonosis, Emerging Disease, and Drug Resistance
The Microbiome and Anal Cancer Pathogenesis in HIV-infected Men who have Sex with Men Joel Palefsky, MD Infectious Disease, HIV/AIDS, Cancer/Oncology
Causes of non-malarial fever in Malawi Teresa Bleakly Kortz, MS, MD Infectious Disease, Pediatrics
ASN100-201: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Safety and Efficacy of a Single Dose of ASN100 for the Prevention of Staphylococcus aureus Pneumonia in Heavily Colonized, Mechanically Ventilated Subjects Anne Luetkemeyer, MD Infectious Disease, Pharmacology and Drug Treatment
Optimal MDR treatment in children Rada Savic, PhD Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis
A smartphone-based point-of-care test for detection of Chlamydia trachomatis Julius Schachter, PhD Sexually Transmitted Infections (STIs), Drug and Diagnostics Development
Effects of blood conservation and donor characteristics on transfused patient outcomes in a large community hospital network Edward Murphy, MD, MPH Transfusion Medicine, Health Systems Strengthening
Research Training at the Confluence of Infectious and Non-Communicable Disease Dean Schillinger, MD Infectious Disease, Neglected Tropical Diseases (NTDs), Training International Scholars and Clinicians, Residencies, Fellowships, and Postdoctoral Training
A Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Glecaprevir (GLE)/Pibrentasvir (PIB) in Adults with Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 Infection Mandana Khalili, MD Infectious Disease, Pharmacology and Drug Treatment
Master Agreement: Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) - International Sites Edward Murphy, MD, MPH HIV/AIDS, Transfusion Medicine, Epidemiology and Surveillance, Training and Capacity Building
Master Agreement: Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) - Domestic Sites Edward Murphy, MD, MPH HIV/AIDS, Transfusion Medicine, Epidemiology and Surveillance
Strategic Information Technical Assistance Consortium George Rutherford, MD Infectious Disease, Epidemiology and Surveillance
Identification of Cobra-specific antibodies Charles Craik, PhD Zoonosis, Emerging Disease, and Drug Resistance, Immunology
Gene circuits that control morphology in Histoplasma Anita Sil, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection
A Phase 3, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Switching from Tenofovir Disoproxil Fumarate (TDF) 300 mg QD to Tenofovir Alafenamide (TAF) 25mg QD in Subjects with Chronic Hepatitis B who are Virologically Suppressed Mandana Khalili, MD Infectious Disease
M14-730 (EXPEDITION-2): A Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults with Chronic Hepatitis C Virus (HCV) Genotype 1-6 Infection and Human Immunodeficiency Virus-1 (HIV-1) Co-Infection Anne Luetkemeyer, MD Infectious Disease, HIV/AIDS, Pharmacology and Drug Treatment
Developing and adapting innovative diagnostic assays for low-resource settings Dianna Ng, MD Infectious Disease, Drug and Diagnostics Development
Bioinformatics pipeline for ultrarapid pathogen identification from next-generation sequencing of clinical samples Taylor Sittler, MD Infectious Disease, Drug and Diagnostics Development
Individual, social, and structural factors on disease transmission in marginalized populations Meghan Morris, PhD, MPH HIV/AIDS, Infectious Disease, Access or Barriers to Care
Incidence, Prevalence and Risk Factors for Sexually Transmitted Infections in Fiji Deborah Dean, MD, MPH Infectious Disease, Sexually Transmitted Infections (STIs), Drug and Diagnostics Development
Improving care delivery for people living with HIV, TB and other chronic diseases through diplomacy Michael J. Reid, MD Infectious Disease, Sexually Transmitted Infections (STIs), HIV/AIDS, Opportunistic Infection, Tuberculosis, Policy and Standards of Care, Systematic Reviews and Guideline Development, Health Systems Strengthening
International Training in Transfusion Medicine Mike Busch, MD, PhD Infectious Disease, Transfusion Medicine, Epidemiology and Surveillance, Health Systems Strengthening, Training International Scholars and Clinicians
Clinical care and medical education David Sears, MD Infectious Disease, HIV/AIDS, Malaria
Viral metagenomics to discover viruses Eric Delwart, PhD Transfusion Medicine, Drug and Diagnostics Development, Epidemiology and Surveillance
Epidemiology of infectious disease Travis Porco, PhD, MPH Infectious Disease, Eye Disease and Blindness, Epidemiology and Surveillance
Identifying the role of opportunistic pathogens including Giardia, Cryptosporidia, Microsporidia and Mycobacterium avium Robert Owen, MD Opportunistic Infection, Zoonosis, Emerging Disease, and Drug Resistance, Occupational and Environmental Disease
Blood safety standards and lab capacity in low & mid income countries Elizabeth Donegan, MD HIV/AIDS, Infectious Disease, Transfusion Medicine, Training International Scholars and Clinicians, Distance learning and mentoring
Evidenced-based guidelines specific to resource challenged settings Teresa Bleakly Kortz, MS, MD Infectious Disease, Health Systems Strengthening
Epidemiology of vector borne diseases Isabel Rodriguez Barraquer, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Epidemiology and Surveillance
Epidemiology of leishmaniasis and schistosomiasis Donald Heyneman, PhD Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
Disease susceptibility and global distribution of genetic variation Mark Seielstad, PhD HIV/AIDS, Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Transfusion Medicine, Genetics, Epidemiology and Surveillance
How Zika virus disrupts neuronal cellular architecture Jeremy Reiter, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance
A Randomized, Double-Blind Evaluation of the Antiviral Efficacy, Safety, and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Pediatric Patients with Chronic Hepatitis B Infection Infectious Disease
Transfusion science and HIV, HTLV, and dengue research in Brazil Philip Norris, MD Infectious Disease, HIV/AIDS, Immunology, Health Systems Strengthening, Risk Reduction and Prevention, Training and Capacity Building
Immunology & epidemiology of intestinal infectious diseases Robert Owen, MD Zoonosis, Emerging Disease, and Drug Resistance, Immunology, Epidemiology and Surveillance
AIDS Education and Training Center, National Clinician Consultation Center Ronald Goldschmidt, MD Infectious Disease, Sexually Transmitted Infections (STIs), HIV/AIDS, Training International Scholars and Clinicians, Residencies, Fellowships, and Postdoctoral Training, UCSF Professional Education, Patient and Peer Education
Anal Dysplasia SCC Supplement for P30 Cancer Support Grant to Stimulate HIV/AIDS Cancer Research Projects NCI-designated Cancer Centers Joel Palefsky, MD HIV/AIDS, Infectious Disease, Cancer/Oncology
Travel Medicine in Global Health Mary Wilson, MD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
Burkitt’s lymphoma and Kaposi’s sarcoma in Uganda John Ziegler, MD, MSc Infectious Disease, HIV/AIDS
Diagnosis and treatment of infectious keratitis Stephen Mcleod, MD Infectious Disease, Eye Disease and Blindness
Implementation science and reproductive health on sub-Saharan Africa Joelle Brown, PhD HIV/AIDS, Infectious Disease, Sexually Transmitted Infections (STIs), Women's Health, Labor and Delivery, Family Planning
Epidemiology capacity building Nancy Hills, PhD HIV/AIDS, Infectious Disease, Epidemiology and Surveillance
Series Editor for Disease Control Priorities, third edition (DCP3) Dean Jamison, PhD Infectious Disease, Health Economics and Effectiveness, Policy and Standards of Care
Trachoma control in Africa through mass antibiotic administration, and corneal ulcer prevention and treatment in South Asia Thomas Lietman, MD Infectious Disease, Eye Disease and Blindness
Mortality Reduction After Oral Azithromycin Thomas Lietman, MD Infectious Disease, Neglected Tropical Diseases (NTDs), Eye Disease and Blindness, Epidemiology and Surveillance
Vulnerable youth, homelessness, and risk behaviors Colette L. Auerswald, MD, MS HIV/AIDS, Sexually Transmitted Infections (STIs), Access or Barriers to Care, Stigma and Discrimination
Chlamydial sexually transmitted diseases and trachoma Deborah Dean, MD, MPH Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness, Drug and Diagnostics Development
Transfusion medicine and Blood safety: Policy, Diagnostics and Standards development Mike Busch, MD, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Transfusion Medicine, Policy and Standards of Care, Systematic Reviews and Guideline Development, Health Systems Strengthening
The M-PulSe Study: Detecting Pulmonary Edema in Sepsis with Lung Ultrasonography in Malawi Richard J. Wang, MD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance
A Randomized, Double-blind, Placebo-controlled Clinical Trial of Fluconazole as Early Empiric Treatment of Coccidioidomycosis Pneumonia (Valley Fever) in Adults Presenting with Community Acquired Pneumonia (CAP) in Endemic Areas (FLEET-Valley Fever) Nathan N. Stockamp,MD Zoonosis, Emerging Disease, and Drug Resistance, Epidemiology and Surveillance
Dissecting the effect of paracrine responses to Zika virus on neurodevelopment in the human brain Hanna Retallack, AB Zoonosis, Emerging Disease, and Drug Resistance, Immunology
Phase 2, Open-Label, Multicenter, Multi-cohort, Single-Arm Study to Investigate the Safety and Efficacy of Sofosbuvir + Ribavirin in Adolescents and Children with Genotype 2 or 3 Chronic HCV Infection Infectious Disease, Pharmacology and Drug Treatment
International Clinical Research Fellowship Christopher Stewart, MD Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Eye Disease and Blindness, Oral Health, Residencies, Fellowships, and Postdoctoral Training
Understanding the Interpersonal Context of HIV/HCV risk within Injecting Dyads Meghan Morris, PhD, MPH Infectious Disease, Sexually Transmitted Infections (STIs), HIV/AIDS, Cancer/Oncology
Novel methods of pharmacologic monitoring for multidrug resistant tuberculosis treatment in the setting of HIV infection John Metcalfe, MD Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis
Updating HCV treatment engagement paradigms for HIV/HCV coinfected patients Elise Riley, PhD Infectious Disease, HIV/AIDS, Engagement in Care
UZ-UCSF Clinical Trials Unit Zvavahera Chirenje, MD, FRCOG Infectious Disease, HIV/AIDS, Pediatrics, Newborn and Infant Health, Risk Reduction and Prevention
AIDS Clinical Trials Network (ACTG) - Transformative Science Group Vice Chair) Peter Hunt, MD Infectious Disease, HIV/AIDS, Tuberculosis
Viral Hepatitis C Infection Long-term Cohort Study (V-HICS) Marion Peters, MD HIV/AIDS, Infectious Disease
Genomic Technology Development and Infectious Diseases Joseph Derisi, PhD Infectious Disease
Host-pathogen interactions: Unveiling common mechanisms for rewiring host factors in infectious processes Nevan Krogan, PhD, MSc Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Immunology, Genetics
Pan-Genomic Approaches for Comprehensive Blood Screening of Novel or Emerging Infectious Agents Charles Chiu, MD, PhD Infectious Disease
UC Valley Fever Research Initiative Anita Sil, MD, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Genetics
INTERCEPT: Interfering and Co-evolving Prevention and Therapy Raul Andino-Pavlovsky, PhD Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
EV71 intra-host evolution, attenuation and vaccine development Raul Andino-Pavlovsky, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
STD Prevention Training Center George Rutherford, MD Sexually Transmitted Infections (STIs), Residencies, Fellowships, and Postdoctoral Training, UCSF Professional Education
GS-US-380-4030: A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Switching from a Regimen of Dolutegravir and Either Emtricitabine/Tenofovir Alafenamide or Emtricitabine/Tenofovir Disoproxil Fumarate to a Fixed Dose Co Anne Luetkemeyer, MD Infectious Disease, Pharmacology and Drug Treatment
MK-3682B-037-00A: Phase 3 Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-3682B (Grazoprevir/Ruzasvir/Uprifosbuvir) in Participants with Chronic Hepatitis C Virus Genotype 3 Infection Anne Luetkemeyer, MD Infectious Disease, Pharmacology and Drug Treatment
A Combined Pathogen-Host Sequencing Assay for Diagnosis of Lyme and Other Tickborne Infections Charles Chiu, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
(PQ4) Anal HPV infection and anal HSIL among HIV-infected MSM aged 50+ years Joel Palefsky, MD Infectious Disease, HIV/AIDS, Cancer/Oncology
The impact of vector control interventions on adverse birth outcomes. Michelle Roh, MPH Zoonosis, Emerging Disease, and Drug Resistance, Malaria, Women's Health, Newborn and Infant Health
AMC-103: A Phase 2 Evaluation of VGX-3100, a Synthetic DNA Immunotherapy Targeting Human Papillomavirus 16 and 18 E6 and E7 Proteins, for Anal High-Grade Squamous Intraepithelial Lesions (HSIL) in HIV-Positive Individuals Joel Palefsky, MD Infectious Disease, Sexually Transmitted Infections (STIs)
Long-term Effects of IDU, HIV, HCV and the Impact of HCV Cure on Immune Activation and Liver Fibrosis in Aging Women Phyllis Tien, MD Infectious Disease, HIV/AIDS, Immunology, Women's Health
HepC/HIV website Susan Coffey, MD HIV/AIDS, Infectious Disease
University of California Global Health Institute Program for Fellows and Scholars Craig Cohen, MD, MPH Infectious Disease, HIV/AIDS, Tuberculosis, Malaria, Surgery and Anesthesia, Cancer/Oncology, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Eye Disease and Blindness, Oral Health, Dementia and Cognitive Impairment, Trauma and PTSD, Women's Health, Pediatrics, Policy and Standards of Care, Epidemiology and Surveillance
Investigating fundamental gaps in Valley Fever knowledge Anita Sil, MD, PhD Infectious Disease, Occupational and Environmental Disease
HPMI: Host Pathogen Mapping Initiative Nevan Krogan, PhD, MSc Zoonosis, Emerging Disease, and Drug Resistance, Immunology, Genetics
Research training in HIV-related transfusion medicine and hematology in South Africa Edward Murphy, MD, MPH HIV/AIDS, Transfusion Medicine, Health Systems Strengthening, Training and Capacity Building
Biology of Infectious Diseases Training Program Henry Chambers, MD Infectious Disease, Training and Capacity Building
Chemical Methods for Ferrous Iron Dependent Drug Delivery Adam Renslo, PhD Zoonosis, Emerging Disease, and Drug Resistance
Insect adaptive immunity Raul Andino-Pavlovsky, PhD Zoonosis, Emerging Disease, and Drug Resistance
Visceral leishmaniasis control in India Caryn Bern, MD, MPH Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
Role of HIV in acceleration of HPV malignancy Sharof Tugizov, PhD HIV/AIDS, Sexually Transmitted Infections (STIs), Cancer/Oncology
Mentoring translational scientists in international infectious disease research Bryan Greenhouse, MD Infectious Disease, Malaria, Residencies, Fellowships, and Postdoctoral Training
Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate Efficacy & Safety of Pimodivir in Combination With Standard-of-care Treatment in Adolescent, Adult, and Elderly Hospitalized Patients With Influenza A Infection Steven Stoltz, MD Infectious Disease, Pharmacology and Drug Treatment
Program for Resistance, Immunology, Surveillance & Modeling of Malaria in Uganda (PRISM) Renewal Grant Dorsey, MD Zoonosis, Emerging Disease, and Drug Resistance, Malaria, Epidemiology and Surveillance
Evaluation of doxycycline post-exposure prophylaxis to reduce sexually transmitted infections in PrEP users and HIV-infected men who have sex with men Anne Luetkemeyer, MD Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance
Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, & Pharmacokinetics of Orally Administered ALS-008176 Regimens in Adults Hospitalized with Respiratory Syncytial Virus Steven Stoltz, MD Infectious Disease, Drug and Diagnostics Development

Active Projects: 391

Project Investigator All Topics Start date End date
HIV Clinical Scholars Fellowship Royce Lin, MD Infectious Disease, HIV/AIDS, Training International Scholars and Clinicians
HIV Clinical Scholars Fellowship Royce Lin, MD Infectious Disease, HIV/AIDS, Residencies, Fellowships, and Postdoctoral Training
Chlamydia and Gonococcal Infection: Immunobiology in the Female Reproductive Tract Craig Cohen, MD, MPH Infectious Disease, Sexually Transmitted Infections (STIs), Women's Health
Acceptability of Barrier Methods for Disease Prevention Sexually Transmitted Infections (STIs)
San Francisco STDs CRC Sexually Transmitted Infections (STIs), Adolescent Health
Retrovirus Epidemiology Donor Study (REDS) Edward Murphy, MD, MPH Infectious Disease, Transfusion Medicine, Health Systems Strengthening, Risk Reduction and Prevention
Acceptability of Diaphragm Use to Prevent STDs/HIV Sexually Transmitted Infections (STIs), Women's Health
Intervention to Decrease Risk for STDs and Unintended Pregnancies in Active Duty Military Women Sexually Transmitted Infections (STIs), Women's Health, Family Planning
Proposed Experiments to Study Emergence of Antimicrobial Resistance in Methicillin- Resistant Strains of Staphylococcus aureus Henry Chambers, MD Zoonosis, Emerging Disease, and Drug Resistance
Pathophysiology of HTLV-I and HTLV-II Infection Edward Murphy, MD, MPH Transfusion Medicine
Mycoplasma Genitalium in the Female Genital Tract Craig Cohen, MD, MPH Infectious Disease, Sexually Transmitted Infections (STIs), Women's Health
Cap Independent Translation of Dengue Virus Raul Andino-Pavlovsky, PhD Zoonosis, Emerging Disease, and Drug Resistance
Population Genetics of the PO1 Locus of SIV and HIV-1 Eric Delwart, PhD HIV/AIDS, Transfusion Medicine, Genetics, Epidemiology and Surveillance
Women and Infants Transmission Study - Human Papillomavirus Protocol Joel Palefsky, MD Infectious Disease, HIV/AIDS, Cancer/Oncology, Women's Health
State Sexually Transmitted Disease Collaborative Program George Rutherford, MD Sexually Transmitted Infections (STIs), Epidemiology and Surveillance, Risk Reduction and Prevention
A Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Adults with Compensated Chronic Hepatitis B Mandana Khalili, MD Infectious Disease
Natual History of Acute and Chronic HCV in Blood Donors Eric Delwart, PhD Infectious Disease, Transfusion Medicine, Epidemiology and Surveillance, Health Systems Strengthening
Improving Uses of New and Existing Technologies to Reduce Non-viral STIs in Developing Countries Sexually Transmitted Infections (STIs)
HIV Risk Reduction Through HSV-2 Prevention with N-9 Sexually Transmitted Infections (STIs)
Sexually Transmitted Disease Prevention Projects: Implementation George Rutherford, MD Sexually Transmitted Infections (STIs), Epidemiology and Surveillance, Risk Reduction and Prevention
Drug Resistant Malaria Clinical and Laboratory Studies Zoonosis, Emerging Disease, and Drug Resistance, Malaria
HCV Infection and Treatment in Parolees: Feasibility Study Kimberly Page, PhD, MPH Sexually Transmitted Infections (STIs)
High Throughput Assay for Screening Compounds Against T. Brucei Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Pharmacology and Drug Treatment
Development and Testing of New Medications for the Treatment of Emerging Infectious Diseases [I] Philip J. Rosenthal, MD Infectious Disease, Drug and Diagnostics Development
Optimization of Cysteine Protease Inhibitors Targeting Trypanosoma Brucei Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Pharmacology and Drug Treatment
Enfuvirtide Intensification for Multi-Drug Resistant HIV Steven Deeks, MD Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Pharmacology and Drug Treatment
Investigation of the Natural History of Human Papillomavirus (HPV) DNA and Cervical Neoplasia in a Cohort of Sex Workers in Kenya Craig Cohen, MD, MPH Infectious Disease, Sexually Transmitted Infections (STIs), Women's Health
Hemin Receptor Gene Family of Bartonella quintana Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance
STD Risks and Latino Adolescents' Sexual Networks Sexually Transmitted Infections (STIs), Adolescent Health
Outreach-based STI and HIV testing for street youth in San Francisco Colette L. Auerswald, MD, MS Sexually Transmitted Infections (STIs), HIV/AIDS, Adolescent Health, Stigma and Discrimination, Risk Reduction and Prevention
Randomized Controlled Trial of 6% Cellulose Sulfate Gel and the Effect on Vaginal HIV Transmission Ariane Van der Straten, PhD, MPH Sexually Transmitted Infections (STIs), HIV/AIDS, Pharmacology and Drug Treatment
Insulin Resistance in HCV Infection Mandana Khalili, MD Sexually Transmitted Infections (STIs)
Applied Research on Antimicrobioal Resistance: Molecular Epidemiology of Community Methicillin-resistant Staphylococcus aureus (MRSA) Henry Chambers, MD Zoonosis, Emerging Disease, and Drug Resistance
Protocol Development for a Phase 2 Study Evaluating the Safety and Feasibility of Ceftobiprole Compared to Conventional Therapy in the Treatment of Subjects w/ Staphylococcus aureus Bacteremia Henry Chambers, MD Infectious Disease, Pharmacology and Drug Treatment
HSV-2 Avidity Testing for Intervention for Male Sexually-Transmitted Disease (STD) Patients in India Christina (Krysia) Lindan, MD, MSc Sexually Transmitted Infections (STIs), HIV/AIDS
Schistosoma mansoni: Identification and Validation of New Targets for Therapy Using a siRNA Screen Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
Strategies for the Control and Elimination of Blinding Trachoma Thomas Lietman, MD Infectious Disease, Neglected Tropical Diseases (NTDs), Eye Disease and Blindness
The Connie Wofsy Womens' HIV Study Ruth Greenblatt, MD Infectious Disease, HIV/AIDS, Women's Health
PEGASYS plus Copegus in treatment-naïve Latino patients with chronic hepatitis C-genotype 1, as compared to treatment-naïve non-Latino White patients with chronic hepatitis C-genotype 1 Mandana Khalili, MD Infectious Disease
A Phase I Safety Trial of the Diaphragm in Zimbabwe Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health, Family Planning
What is the Appropriate Frequency and Duration of Mass Azithromycin Thomas Lietman, MD Neglected Tropical Diseases (NTDs), Eye Disease and Blindness, Pharmacology and Drug Treatment
XI International Conference on Human Retrovirology: HTLV Edward Murphy, MD, MPH HIV/AIDS, Transfusion Medicine
Anal Human Papillomavirus (HPV) in Methamphetamine (MA) Using and Non-Using Men Who Have Sex with Men (MSM) in Los Angeles Joel Palefsky, MD Infectious Disease, Cancer/Oncology, Substance Abuse, Risk Reduction and Prevention
An Intervention for Male STD Patients in India / HIV Related Christina (Krysia) Lindan, MD, MSc Sexually Transmitted Infections (STIs), HIV/AIDS
Novel Anti-Malarials by Combinatorial Pharmacogenomics Joseph Derisi, PhD Infectious Disease, Malaria, Drug and Diagnostics Development
Providers' Perceptions of the Diaphragm in Southern Africa and the United States Cynthia Harper, PhD Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health, Training International Scholars and Clinicians, UCSF Professional Education
Natural History of Acute and Chronic HCV in Blood Donors Edward Murphy, MD, MPH Infectious Disease, Transfusion Medicine
Specialized Infectious Disease Control Program George Rutherford, MD Infectious Disease
Host Protein Degradation by Schistosome Parasites Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Pharmacology and Drug Treatment
Phase 2 Study, Safety of and Rate of Bacterial Clearance of Ceftobiprole Compared to Conventional Therapy in the Treatment of Subjects w/ Staphylococcus aureus Bacteremia Henry Chambers, MD Infectious Disease, Pharmacology and Drug Treatment
A Phase 2, Randomized, Open-Labeled Study on the Safety of and Rate of Bacterial Clearance of Ceftobiprole Compared to Conventional Therapy in the Treatment of Subjects w/ Staphylococcus aureus Bacteremia Henry Chambers, MD Infectious Disease, Pharmacology and Drug Treatment
Hepatocellular Carcinoma Screening Practices in Hepatitis B (HBV) Infected Asian Americans Mandana Khalili, MD Infectious Disease
Regulation of the Development of Tryanosoma brucei Neglected Tropical Diseases (NTDs)
The Incidence of Bacillary Angiomatosis in Uganda Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection
Acute Hepatitis C Infection in Young Injectors Kimberly Page, PhD, MPH Sexually Transmitted Infections (STIs)
Economic Opportunity for Zimbabwean Adolescent Orphans Philip Darney, MD, MS Sexually Transmitted Infections (STIs), HIV/AIDS
Specialized Infectious Disease Control Program George Rutherford, MD Infectious Disease
Hcv-Induced Alterations in Glucose Metabolism Mandana Khalili, MD Infectious Disease, Diabetes
Clinical Epidemiology of HTLV-I and HTLV-II Infection Edward Murphy, MD, MPH Transfusion Medicine
Multidrug-Resistant CA-MRSA Infections Among HIV+ Persons: CA AIDS Grant ID07-REI-129 Henry Chambers, MD Infectious Disease, Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Epidemiology and Surveillance
Bartonella Virulence Mechanisms in Patients with AIDS Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS
Treatment of Acute Hepatitis C Virus in HIV Co-Infection Sexually Transmitted Infections (STIs), HIV/AIDS
Phase III Trial of the Efficacy and Safety of Clevudine Compared With Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Naïve Patients With HBeAg Negative Chronic Hepatitis Due to Hepatitis B Virus Mandana Khalili, MD Infectious Disease, Pharmacology and Drug Treatment
Phase III Trial of the Efficacy and Safety of Clevudine Compared With Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Naïve Patients With HBeAg Negative Chronic Hepatitis Due to Hepatitis B Virus Mandana Khalili, MD Infectious Disease
PCP OPW Specimens/Uganda Project Support Laurence Huang, MD Infectious Disease, HIV/AIDS, Opportunistic Infection
State Sexually Transmitted Disease Collaborative Program George Rutherford, MD Sexually Transmitted Infections (STIs)
Regulation of the Development of Trypanosoma brucei Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
UCDRD Whitepaper: Viral Pathogens Joseph Derisi, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance
Pathophysiology of HTLV-I and HTLV-II Infection Edward Murphy, MD, MPH Transfusion Medicine
Subcontract Work in Association with LLNL LDRD Project: COMP-08ERD036 Raul Andino-Pavlovsky, PhD Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Support for Male Circumcision Evaluatation Meeting George Rutherford, MD Sexually Transmitted Infections (STIs), HIV/AIDS, Risk Reduction and Prevention
Transcriptional Responses of Parasite and Host during Intestinal Colonization and Invasion by Entamoeba histolytica Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Pharmacology and Drug Treatment
Sangre Segura: An Epidemiological Study of Blood Transfusion Safety in the Mexico-U.S. Border Region Edward Murphy, MD, MPH Infectious Disease, Transfusion Medicine, Health Systems Strengthening, Risk Reduction and Prevention
Valley Fever Vaccine Project George Rutherford, MD Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection, Occupational and Environmental Disease, Drug and Diagnostics Development
Tetrezolid vs. Daptomycin and Vancomycin for Treatment of Experimental Staphylococcus aureus Henry Chambers, MD Infectious Disease, Pharmacology and Drug Treatment
The Medical Consequences of Different Types of Heroin Daniel Ciccarone, MD, MPH Infectious Disease, HIV/AIDS, Substance Abuse
Central Nervous System Events in Primary HIV Infection Infectious Disease, HIV/AIDS, Neurology and Mental Health
Targeting Cysteine Proteases--Antiparasitic Chemotherapy Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Pharmacology and Drug Treatment
Purine Metabolism in Trichomonas Vaginalis Infectious Disease, Sexually Transmitted Infections (STIs)
Microbicide Pregnancy Registry--Microbicide Trials Network Juan Vargas, MD Sexually Transmitted Infections (STIs), HIV/AIDS, Drug and Diagnostics Development, Women's Health, Family Planning
Ceftobiprole vs. Daptomycin and Linezolid for Treatment of Experimental Staph. aureus Endocarditis in Rabbits Henry Chambers, MD Infectious Disease, Pharmacology and Drug Treatment
HIV, Hepatitis C, and Pruritus: Data from the Women's Interagency HIV Study Toby Maurer, MD Infectious Disease, HIV/AIDS, Women's Health
Hepatitis C: Studies of Immunity and Pathogenesis Kimberly Page, PhD, MPH Sexually Transmitted Infections (STIs)
Congenital Syphilis Elimination Cost-Effectiveness Analysis James Kahn, MD, MPH Sexually Transmitted Infections (STIs), Health Economics and Effectiveness
ADS-TCAD-P0206: TCAD Oral for Treatment of Influenza A Diane Havlir, MD Infectious Disease, HIV/AIDS, Opportunistic Infection, Pharmacology and Drug Treatment
Satellite Symposium at Microbicides 2010 on Bacterial Therapeutics Craig Cohen, MD, MPH Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health
UZ-UCSF Clinical Trials Unit Zvavahera Chirenje, MD, FRCOG Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health
Entecavir Intensification for HIV-HBV Coinfected subjects with persistent HBV viremia Anne Luetkemeyer, MD Infectious Disease, HIV/AIDS, Pharmacology and Drug Treatment
Content from UCSF Physicians for SexReally.com J. Joseph Speidel, MD, MPH Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health, Family Planning, Adolescent Health, Patient and Peer Education
HIV-HEP C Website Maintenance Services Susan Coffey, MD Infectious Disease, HIV/AIDS, Patient and Peer Education
Core B: Intracellular Pathogens and Innate Immunity Joseph Derisi, PhD Zoonosis, Emerging Disease, and Drug Resistance, Immunology
Prevention of Emergence of Antibiotic Resistant P. aeruginosa Zoonosis, Emerging Disease, and Drug Resistance
Genomic and Clinical Correlates of Human Bartonella Quintana Infection Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance
Valley Fever Vaccine Project 2010 George Rutherford, MD Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection, Occupational and Environmental Disease, Drug and Diagnostics Development
Retrovirus Epidemiology Donor Study-II (REDS-II) Central Laboratory Mark Seielstad, PhD Infectious Disease, Sexually Transmitted Infections (STIs), Transfusion Medicine, Health Systems Strengthening
Research Training in International Transfusion Safety Edward Murphy, MD, MPH Transfusion Medicine, Health Systems Strengthening, Training International Scholars and Clinicians
The Impact of Anogenital Human Papillomavirus in the Transmission of HIV in Urban Brazil: Phase II Study Joel Palefsky, MD Infectious Disease, Pharmacology and Drug Treatment
Identification of Anti-HIV Lead Compounds Targeting Adam Renslo, PhD Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS
Retrovirus Epidemiology Donor Study-II REDS-II International Component - Blood Center Edward Murphy, MD, MPH Infectious Disease, Transfusion Medicine, Health Systems Strengthening
The Steroids for Corneal Ulcers Trial Thomas Lietman, MD Infectious Disease, Eye Disease and Blindness, Pharmacology and Drug Treatment
Development and Testing of New Medications for the Treatment of Emerging Infectious Diseases [II] Philip J. Rosenthal, MD Infectious Disease, Neglected Tropical Diseases (NTDs), Malaria
Identification of Novel Small Molecule Therapeutics for Visceral Leishmaniasis Adam Renslo, PhD Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
Janssen/Sakanari - flubendazole study 20150930 Judy Sakanari, PhD Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Identification of Novel Small Molecule Therapeutics for Visceral Leishmaniasis Adam Renslo, PhD Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
Elimination of Infectious Trachoma from Ethiopia Using Repeated Mass Antibiotic Distributions Thomas Lietman, MD Infectious Disease, Neglected Tropical Diseases (NTDs), Eye Disease and Blindness
Virus population dynamics, genetic diversity and evolution Raul Andino-Pavlovsky, PhD Zoonosis, Emerging Disease, and Drug Resistance
Programmable Genetic Memory in Bacteroides: Diagnosis of Diarrheal Disease Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Pediatrics, Newborn and Infant Health
Diagnosis, Prevention, and Management of Cryptococcus Infection (Meningeal and Non-Meningeal) George Rutherford, MD Infectious Disease, HIV/AIDS, Opportunistic Infection
HIV Emergence of Drug Resistance Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Pharmacology and Drug Treatment
Trypanosome Drug Development Consortium Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development
Iron-Dependent Drug Delivery as a New Paradigm in Anti-Parasitic Chemotherapy and Prophylaxis Adam Renslo, PhD Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development
Leveraging Core Groups -- A New Way to Protect Against Infectious Trachoma Thomas Lietman, MD Infectious Disease, Eye Disease and Blindness, Epidemiology and Surveillance
Microbicide Pregnancy Registry-Microbicide Trials Network Juan Vargas, MD Sexually Transmitted Infections (STIs), HIV/AIDS, Drug and Diagnostics Development, Women's Health
Secretion of Virulence Factors by Mycobacterium tuberculosis Infectious Disease, HIV/AIDS, Tuberculosis, Genetics
XV International Conference on Human Retrovirology: HTLV and Related Viruses Edward Murphy, MD, MPH HIV/AIDS, Infectious Disease, Transfusion Medicine
Dynamic Modeling of the Hepatitis C Epidemic in Injection Drug Users Judith Hahn, PhD, MD Sexually Transmitted Infections (STIs), Epidemiology and Surveillance
Meeting cholera's challenge to Haiti and the world: a joint statement on cholera prevention and care Infectious Disease, Health Economics and Effectiveness, Policy and Standards of Care
Natural History and Outcomes of Coccidioidomycosis Retrospective Record Review Study Infectious Disease, Opportunistic Infection, Systematic Reviews and Guideline Development
Efficacy Evaluation and Safety of Single-dose IV Oritavancin vs. IV Vancomycin for the Treatment of Patients with Acute Bacterial Skin and Skin Structure Infection (SOLO I) Henry Chambers, MD Infectious Disease
Expanded Access to MGAWN1 in Subjects with Suspected West Nile Neuroinvasive Disease; Substantial Exposure, or Infection and a Compromised Immune System Jeffrey Ralph, MD Zoonosis, Emerging Disease, and Drug Resistance, Pharmacology and Drug Treatment
Regulatory Networks That Control Cell Morphology and Virulence in the Fungal Respiratory Pathogen Histoplasma capsulatum Infectious Disease
Vitamin A Metabolism and Helminth Infection Mike McCune, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
Hepatitis C Co-infection Clinic: A to T (Acute to Transplant) Sexually Transmitted Infections (STIs), HIV/AIDS
To Discover and Characterize Novel Viruses in Cancer Charles Chiu, MD, PhD Infectious Disease, Cancer/Oncology
Trial of T.cruzi DNA Vaccine in Experimental Model of Disease Challenge Infection Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development
Viral & Rickettsial Disease Laboratory (VRDL) Project George Rutherford, MD Infectious Disease
Viral Discovery in Human and Animal Samples Charles Chiu, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Efficacy and Safety of Eraxis/Ecalta (Anidulafungin) Compared to Cancidas (Caspofungin) in Patients with Candida Deep Tissue Infection: A Phase 4 Study Infectious Disease, HIV/AIDS, Opportunistic Infection, Pharmacology and Drug Treatment
Evaluation of Abbott RealTime CT/NG for the Detection of C. trachomatis & N. gonorrhoeae from the Pharynx, Rectum & Urethra of MSM Julius Schachter, PhD Sexually Transmitted Infections (STIs)
Detection of Viral Pathogens in Indian Patients Who Have Suspected Viral Encephalitis Infectious Disease
RNA Interference and High-Content Image Analysis to Discover New Drug Targets to Treat the Tropical Disease Schistosomiasis Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development
RNAi as an Intercellular Antiviral Defense Mechanism Raul Andino-Pavlovsky, PhD Infectious Disease, Genetics
Novel Mechanisms of Beta-Lactam Resistance in Staph aureus Henry Chambers, MD Zoonosis, Emerging Disease, and Drug Resistance
Translational Studies of Antimalarial Drug Resistance Philip J. Rosenthal, MD Zoonosis, Emerging Disease, and Drug Resistance, Malaria
A New Field Assay to Diagnose and Monitor Schistosomiasis Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
WSA-CS-003: Open Label Study of Isavuconazole in the Treatment of Patients with Aspergillosis and Renal Impairment or of Patients with Invasive Fungal Disease Caused by Rare Molds, Yeasts or Dimorphic Fungi Infectious Disease, Opportunistic Infection, Pharmacology and Drug Treatment
Framework to Address Drug Resistant Infections and Global Health Joseph Derisi, PhD Infectious Disease
Study of Telaprevir in Combination With Peginterferon Alfa-2a (Pegasys®) and Ribavirin (Copegus®) in Subjects Who Have Chronic HCV-1/HIV-1 Co-Infection and Are Treatment-Naïve for Hepatitis C Infectious Disease, HIV/AIDS
Using Pan-Pathogen Microarrays and Deep Sequencing to Search for the Cause of Southern Tick-Associated Rash Illness (STARI) Charles Chiu, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance
Predicting and Improving Critical Outcomes for Bacterial Keratitis Nisha Acharya, MD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness
Chemical Methods for Ferrous Iron Targeted Drug Delivery Adam Renslo, PhD Zoonosis, Emerging Disease, and Drug Resistance, Malaria
Translation Regulation in Giardia lamblia Infectious Disease, Genetics
Retrovirus Epidemiology and Donor Evaluation Study-III (REDS-III) - International Sites Edward Murphy, MD, MPH HIV/AIDS, Transfusion Medicine, Epidemiology and Surveillance
Novel Therapeutics for Class B Protozoa Neglected Tropical Diseases (NTDs)
Epidemiologic Effects of ART on HIV-related Anal Cancer and Anal Dysplasia Joel Palefsky, MD Infectious Disease, HIV/AIDS, Cancer/Oncology
A Rapid Pan-Viral Microarray Diagnostic for Category A-C Biodefense Pathogens Charles Chiu, MD, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Early Diagnosis of Human Prion Disease Michael Geschwind, MD, PhD Infectious Disease, Drug and Diagnostics Development
K777 for the Treatment of Chagas' Disease, IND-enabling Studies and IND Submission Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development
In Utero Model to Assess the Fate of Transplanted Human Cells for Translational Research and Pediatric Therapies Mike McCune, MD, PhD Infectious Disease, Neglected Tropical Diseases (NTDs), Pediatrics
Prospective Observational Multi-Center Transfusion Study (PROMMTT) Transfusion Medicine, Trauma and PTSD
HCV Prevention and Care Education Kimberly Page, PhD, MPH Infectious Disease, Sexually Transmitted Infections (STIs), Patient and Peer Education
CDC Preparedness and Emergency Response Research Center Travis Porco, PhD, MPH Zoonosis, Emerging Disease, and Drug Resistance
Mycotic Ulcer Treatment Trial (MUTT) Nisha Acharya, MD Infectious Disease, Eye Disease and Blindness
Regulation of the Development of Trypanosoma brucei Neglected Tropical Diseases (NTDs)
C. elegans as a Targeted Molecular Surrogate for Filarid Parasites 2 Kaveh Ashrafi, PhD Zoonosis, Emerging Disease, and Drug Resistance
Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) - Central Laboratory Mark Seielstad, PhD HIV/AIDS, Transfusion Medicine, Epidemiology and Surveillance
Predicting and Improving Outcomes in Bacterial and Fungal Keratitis Nisha Acharya, MD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness
Research to Programs for Trachoma Elimination Thomas Lietman, MD Infectious Disease, Eye Disease and Blindness, Pharmacology and Drug Treatment, Epidemiology and Surveillance
Microbicide Pregnancy Registry--Microbicide Trials Network Juan Vargas, MD Sexually Transmitted Infections (STIs), Drug and Diagnostics Development, Women's Health, Family Planning
Identifying Community Factors Impacting STIs among Youth in California Claire Brindis, DrPH Sexually Transmitted Infections (STIs), Adolescent Health
Digital Disease Detection and Molecular Epidemiology of Viral Pathogens in Peru Infectious Disease, Epidemiology and Surveillance
Trial of T.cruzi DNA Vaccine in Experimental Model of Disease Challenge Infection Neglected Tropical Diseases (NTDs)
Public Health Research, Epidemiology, and Surveillance for Hemoglobinopathies (PHRESH) Sickle Cell Disease (SCD)/ Thalassemia Case Reporting James Huang, MD Infectious Disease, Genetics, Health Systems Strengthening, Risk Reduction and Prevention
Trachoma in Southwestern Nepal Deborah Dean, MD, MPH Infectious Disease, Eye Disease and Blindness
TO#1: Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) - International Sites Edward Murphy, MD, MPH Infectious Disease, Transfusion Medicine, Systematic Reviews and Guideline Development, Epidemiology and Surveillance
Genetic Diversity as a Determinant of Viral Pathogenesis and Attenuation Raul Andino-Pavlovsky, PhD Infectious Disease, Genetics, Risk Reduction and Prevention
Broad-UCSF Visceral Leishmania Screening Collaboration Neglected Tropical Diseases (NTDs)
VX11-950-115 An Open Label, Phase 3 Study of Telaprevir in Combination With Peginterferon Alfa 2a (Pegasys®) and Ribavirin (Copegus®) in Subjects Coinfected With Genotype 1 Hepatitis C Virus and Human Immunodeficiency Virus Type 1(HCV/HIV-1) Sexually Transmitted Infections (STIs), HIV/AIDS
Diagnostic Antibody for Type A Botulism Infectious Disease, Drug and Diagnostics Development
Biotest Analysis for HCMV Infection in Placentas Lenore Pereira, PhD Infectious Disease, Pharmacology and Drug Treatment, Women's Health, Newborn and Infant Health
Detection and Discovery of Viral Pathogens Associated with Dengue-like Symptoms in Nicaragua Joseph Derisi, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Epidemiology and Surveillance
Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) - Domestic Hub Edward Murphy, MD, MPH HIV/AIDS, Transfusion Medicine, Epidemiology and Surveillance
Anal Cytology/HPV Testing Study Joel Palefsky, MD Infectious Disease, Cancer/Oncology, Systematic Reviews and Guideline Development
Broad Spectrum Antivirals Targeting Envelope Proteolysis and Viral Uncoating Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development
Student and Postdoctoral Collaborations Travel Award Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Residencies, Fellowships, and Postdoctoral Training
Regulation of Virulence Traits in a Fungal Pathogen of Cancer Patients Zoonosis, Emerging Disease, and Drug Resistance, Occupational and Environmental Disease
2013 NIH Workshop on Protein Homeostasis and Viral Infection Raul Andino-Pavlovsky, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance
Comprehensive Diagnostics for Viral Encephalitis/Meningitis Charles Chiu, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Lead Identification to Clinical Candidate Selection: Drugs for Chagas' Disease Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development
Identification and Validation of Targets of Phenotypic High Throughput Screening Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development
A Phase 2, Open-Label Study of Daclatasvir (BMS-790052) and TMC435 in Combination With or Without Ribavirin (RBV) For Treatment-Naive Subjects or Null Responders to Prior Peginterferon Alfa (PegIFN)/RBV Therapy with Genotype 1 Chronic Hepatitis C Anne Luetkemeyer, MD Sexually Transmitted Infections (STIs)
APTIMA HPV Clinical Study on Anal Specimens from Men Who Have Sex with Men (MSM) Joel Palefsky, MD Sexually Transmitted Infections (STIs)
Multiplexed Viral and Cytokine Response Assays Using NanoString Technology Charles Chiu, MD, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Acute Hepatitis C Infection in Young Injectors Kimberly Page, PhD, MPH Infectious Disease, Adolescent Health, Substance Abuse
Pathogen Discovery in PREDICT Human and Wildlife samples to Detect and Identify Viruses Present, Both Known and Novel Charles Chiu, MD, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Host and Viral Predictors of Prediabetes in at-risk Latinos with Chronic Hepatitis C (HCV) Mandana Khalili, MD Infectious Disease, Diabetes
Screening and Management of Chronic Hepatitis B Virus Infection: A Survey of San Francisco Health Care Providers Mandana Khalili, MD Infectious Disease
Structure and Engineering of Natural Product Cytochrome P450 Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development
UCSF RPB Unrestricted Grant Application Stephen Mcleod, MD Infectious Disease, Eye Disease and Blindness
Clin 0003 Identification and Characterization of a Putative Novel Poxvirus in the DRC Charles Chiu, MD, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Clin 0004 Characterization of Viral Hemorrhagic Fevers of Unknown Origin Charles Chiu, MD, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Tools for the Endgame: Accelerating the development and introduction of Dx to Support the London Declaration 2020 goals for Neglected Tropical Diseases (NTDs) Thomas Lietman, MD Neglected Tropical Diseases (NTDs), Eye Disease and Blindness
Systems-Based Analysis of Flaviviral Host Restriction Nevan Krogan, PhD, MSc Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
Deep Sequencing Clinical Analysis Tool for Infectious Disease Infectious Disease, Drug and Diagnostics Development
Genome-Wide Association Study to Examine Genes Associated with An Increased Risk of Febrile Seizure in Children Following Measles-Containing Vaccines Mark Seielstad, PhD Infectious Disease, Transfusion Medicine, Immunology, Pharmacology and Drug Treatment, Pediatrics, Epidemiology and Surveillance
Bartonella henselae: Mechanisms of Chronic Bloodstream Infection Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance
Gene Circuits that Control Morphology in Histoplasma Anita Sil, MD, PhD Infectious Disease, Opportunistic Infection
HPV Cervical Neoplasia in a Long-Term HIV+ Cohort Joel Palefsky, MD Sexually Transmitted Infections (STIs), Cancer/Oncology, Women's Health
Host-pathogen Interactions during Vertical Transmission of Listeria monocytogenes Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection, Women's Health, Labor and Delivery, Newborn and Infant Health
An Automated High Throughput Phenotypic Screen for Schistosomiasis Drug Discovery Infectious Disease, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development
Preventing Fucose-Dependent Binding of Aspergillus and Pseudomonas to Lung Mucin Infectious Disease, Chronic Respiratory Disease, Genetics
Structure-Aided Design of CYP51 Inhibitors for Treatment of Parasitic Infections Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development
International Clinics on Infectious Disease Dynamics and Data (ICI3D Program) Travis Porco, PhD, MPH Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Training International Scholars and Clinicians
Quasispecies and drug resistance Raul Andino-Pavlovsky, PhD Zoonosis, Emerging Disease, and Drug Resistance
Multimodal Imaging of Antibody-Mediated Therapy for Japanese Encephalitis Virus Michael Wilson, MD Infectious Disease, Drug and Diagnostics Development
Protocol GS-US-334-0139 An Expanded Access Phase 2 Study of Sofosbuvir and Ribavarin with or without Pegylated Interferon for 24 Weeks in Subjects Who Have Undergone Liver Transplantation and Who Have Aggressive Recurrent Hepatitis C Infection Infectious Disease, Cancer/Oncology
In Vivo Drug Interaction Study Sexually Transmitted Infections (STIs), Family Planning
Lead Identification to Clinical Candidate Selection: Drugs for Chagas' Disease Adam Renslo, PhD Zoonosis, Emerging Disease, and Drug Resistance
CCD Study- RNA Sequencing Charles Chiu, MD, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Natural History of HPV Infection to Neoplasia Anna-Barbara Moscicki, MD Infectious Disease
Resistance of Malaria Parasites to Artemisinin-Based Combination Therapies Philip J. Rosenthal, MD Zoonosis, Emerging Disease, and Drug Resistance, Malaria
Family Services Network - Ryan White HIV/AIDS Program Infectious Disease, HIV/AIDS, Systematic Reviews and Guideline Development
Small molecule macrofilaricides targeted against PDE4 Kaveh Ashrafi, PhD Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
Identifying Variants Casual for Type 2 Diabetes in Major Human Populations Mark Seielstad, PhD Transfusion Medicine, Diabetes, Epidemiology and Surveillance
Microbial Pathogenesis and Host Defense Joanne Engel, MD, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Training International Scholars and Clinicians
A schistosome cysteine protease in Th response polarization Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
A Phase 3, Open-label Study to Investigate the Efficacy and Safety of GS-7977 plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) Coinfected Subjects (GS-US-334-0123) Anne Luetkemeyer, MD Sexually Transmitted Infections (STIs)
Mechansims of poliovirus replication Raul Andino-Pavlovsky, PhD Infectious Disease, Noncommunicable and/or Chronic Disease, Genetics
Utility of Contact Investigation of Drug Susceptible and Resistant Tuberculosis in Tanzania Elizabeth Fair, PhD, MPH Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Epidemiology and Surveillance
High throughput proteomics to dissect Chlamydia-host cell interactions Joanne Engel, MD, PhD Infectious Disease, Sexually Transmitted Infections (STIs), Genetics, Risk Reduction and Prevention
TANA II Thomas Lietman, MD Infectious Disease, Neglected Tropical Diseases (NTDs), Eye Disease and Blindness, Pharmacology and Drug Treatment, Epidemiology and Surveillance
The Contribution of Unsafe Blood Transfusion to HIV Transmission in Africa: A Literature Review Malika Morar, MS Transfusion Medicine, Access or Barriers to Care, Systematic Reviews and Guideline Development, Epidemiology and Surveillance, Health Systems Strengthening, Risk Reduction and Prevention
Human papillomavirus and the impact of needle-free vaccination on incidence in Thai women: a quantitative study Sneh Patel, MS Infectious Disease, Cancer/Oncology, Pediatrics
Analysis of the rapid policy change toward empirical treatment of fever with artemisinin-based combination therapy in Ebola-burdened areas of Liberia Matt Susko, MS Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Malaria, Policy and Standards of Care
Phase II-b Randomized Double-Blind Placebo-Controlled Trial of Lactobacillus Crispatus CTV-05 Craig Cohen, MD, MPH Sexually Transmitted Infections (STIs), Women's Health
Pathogen characterization and discovery by deep sequencing of two major vectors associated with Lyme disease and other tickborne infections Charles Chiu, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Replication, Pathogenesis and Evolution of RNA Viruses, Including Dengue Raul Andino-Pavlovsky, PhD Infectious Disease, Neglected Tropical Diseases (NTDs)
Discovery of benzoxaboroles for the treatment of cryptosporidiosis Philip J. Rosenthal, MD Infectious Disease, Drug and Diagnostics Development
Comprehensive Diagnostics for Viral Encephalitis/Meningitis Charles Chiu, MD, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Non-invasive diagnosis of viable adult filarial infections Judy Sakanari, PhD Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
Nanotextured Condoms: Surface Engineering for Better Safe Sex Sexually Transmitted Infections (STIs)
Auranofin supplies to test as a macrofilaricide for human onchocerciasis Jaime Sepulveda, MD, DSc, MPH Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
Targeting host autophagy for treating Mtb infections and synergizing with antibiotics in vivo Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Pharmacology and Drug Treatment
Linking Virus Population Genetic Structure to Infectivity and Adaptation Raul Andino-Pavlovsky, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance
Novel Maltodextrin-Based, Bacterial Targeting Probes for Bioimaging of Viable MTB In Vivo Payam Nahid, MD, MPH Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development
Identifying inhibitors of Parasitic Worm Activity Zoonosis, Emerging Disease, and Drug Resistance
A Clinical Trial for Uncomplicated Skin Infections in Areas of Epidemic Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) Henry Chambers, MD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection
Thai Red Cross S&S, HN177 Joel Palefsky, MD Infectious Disease, Sexually Transmitted Infections (STIs), Cancer/Oncology
Genetic Diversity as a Determinant of Viral Adaptation and Pathogenesis Raul Andino-Pavlovsky, PhD Infectious Disease, Immunology
GS_US_342-1139: Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed Dose Combination for 12 Weeks with Sofosbuvir and Ribavirin for 12 Weeks in Subjects with Chronic Genotype 2 HCV Infecti Anne Luetkemeyer, MD Infectious Disease, Pharmacology and Drug Treatment
Genetics of Brazilian Populations Mark Seielstad, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Transfusion Medicine, Genetics, Epidemiology and Surveillance
Pathogenesis of HIV-Related Bacillary Angiomatosis HIV/AIDS, Opportunistic Infection, Infectious Disease, Cancer/Oncology
Broad Detection of Infectious Agents in Blood by Microarrays and Deep Sequencing Charles Chiu, MD, PhD Infectious Disease, Drug and Diagnostics Development
Processing Uganda Swabs for Trachoma Alternative Indicators Study Julius Schachter, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness
Molecular Dissection of Histoplasma-Induced Host-Cell Death Anita Sil, MD, PhD Infectious Disease
Schistosome Research Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development
Exploring Statins As a Small Molecule Therapy for Treatment of Schistosomiasis Neglected Tropical Diseases (NTDs), Noncommunicable and/or Chronic Disease, Risk Reduction and Prevention
Defining Natural History and Optimal Treatment Outcome for Chronic HBV Infection Infectious Disease
Health Outcomes in Blood Donors and Recipients Edward Murphy, MD, MPH Infectious Disease, Transfusion Medicine, Noncommunicable and/or Chronic Disease, Epidemiology and Surveillance, Risk Reduction and Prevention, Training and Capacity Building, Training International Scholars and Clinicians
Bay Area Hepatitis C Cooperative Research Center Mike McCune, MD, PhD Infectious Disease, Sexually Transmitted Infections (STIs)
Whole Blood/Serum Samples from Patients with Hepatitis Charles Chiu, MD, PhD Infectious Disease, Drug and Diagnostics Development
Trefoil Factors Regulate Th2 Immunity Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Immunology
Treating Snake Envenomation in India: A Costing Analysis for the Adoption of a Small Molecule Therapeutic Simran Dhanju, MS Zoonosis, Emerging Disease, and Drug Resistance
The Impact of Hand Hygiene Medical Aid Films on the Healthcare Workers' Hand Hygiene Practices at Ndola Central Hospital, Zambia: a Mixed Methods Study Hanna Larson, MS Infectious Disease, Pediatrics, Epidemiology and Surveillance, Engagement in Care
Preclinical Development of MucoCept Craig Cohen, MD, MPH Sexually Transmitted Infections (STIs), Women's Health
The Impact of Tolerance in the Newborn on Lentiviral Infection Mike McCune, MD, PhD Infectious Disease, Pediatrics
RAPID: Ebola virus population structure, genetic diversity and evolution Raul Andino-Pavlovsky, PhD Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development, Pharmacology and Drug Treatment
Accurate, long-read sequencing with droplet-microfluidic barcoding Adam Abate, PhD Infectious Disease, Cancer/Oncology, Genetics
Serological prevalence of viral hemorrhagic fevers in Equatorial Africa Charles Chiu, MD, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance
HPV Testing Contract for UPR NIDCR-funded R21, "Detection of HPV infection in the oral cavity of Hispanics with and without periodontal disease" Joel Palefsky, MD Infectious Disease, Oral Health
Kinetoplastid Drug Development: Strengthening the Preclinical Pipeline Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
International Collaborative of prospective studies of HIV and Hepatitis in IDU Sexually Transmitted Infections (STIs), Cancer/Oncology
Mycotic Ulcer Treatment Trial Thomas Lietman, MD Infectious Disease, Neglected Tropical Diseases (NTDs), Eye Disease and Blindness, Pharmacology and Drug Treatment
Global gene array, secretome analyses, and HIV infection analyses of foreskin epithelial cells upon exposure to cervicovaginal fluid from healthy vs. women with bacterial vaginosis Grace Turyasingura, MSc Sexually Transmitted Infections (STIs)
Development of the infant gastrointestinal virome and shedding of oral polio and rotavirus vaccines in Bangladeshi and US infants Charles Chiu, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Newborn and Infant Health
Harvesting of S. Mansoni schistosoma eggs Zoonosis, Emerging Disease, and Drug Resistance
Developing a Macrofilaricidal Drug for Onchocerciasis Using Anacor's Novel Oxaborole Technology Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development
A Phase 3, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed Dose Combination for 12 weeks in Subjects with Chronic HCV and HIV-1 Coinfection Anne Luetkemeyer, MD Infectious Disease, HIV/AIDS, Pharmacology and Drug Treatment
Fighting Infections through Research, Science and Technology (FIRST) Service Contract Jaime Sepulveda, MD, DSc, MPH Neglected Tropical Diseases (NTDs), Health Systems Strengthening
Antibacterial Resistance Leadership Group (ARIG) Henry Chambers, MD Zoonosis, Emerging Disease, and Drug Resistance, Systematic Reviews and Guideline Development
2.1 Project Title ACTG: AIDS Clinical Trials Group Francesca Aweeka, PharmD Infectious Disease, HIV/AIDS, Tuberculosis
Philippine-UC Collaboratory for Device Innovation (Education/Training Award) Michael Harrison, MD Zoonosis, Emerging Disease, and Drug Resistance, Malaria, Drug and Diagnostics Development, Genetics, Training International Scholars and Clinicians
RAPID: Understanding and leveraging asymptomatic infections to control Ebola transmission Travis Porco, PhD, MPH Infectious Disease, Epidemiology and Surveillance
Quantitative mapping of interactions between dengue virus and its hosts Zoonosis, Emerging Disease, and Drug Resistance, Immunology
Fighting emerging antimalarial drug resistance Philip J. Rosenthal, MD Zoonosis, Emerging Disease, and Drug Resistance, Malaria
Signaling by Cytoplasmic Tyrosine Kinases in Leukocytes Infectious Disease, Noncommunicable and/or Chronic Disease, Risk Reduction and Prevention
Sexually Transmitted Infections Clinical Trials Group (STICTG) Linda Giudice, MD, PhD, MSc Sexually Transmitted Infections (STIs)
Digital Disease Detection and Molecular Epidemiology of Viral Pathogens in Peru Infectious Disease, Epidemiology and Surveillance
Metabiota - Viral Surveillance for the PREDICT Program 20150410 Charles Chiu, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development
Real-time projections of Ebola outbreak size and duration with and without vaccine use in Équateur, Democratic Republic of Congo Dan Kelly, MD, MPH Infectious Disease, Epidemiology and Surveillance, Global Strategic Information
Study for Sample Acquisition for Patients Diagnosed with S. aureus Bacteremia Henry Chambers, MD Infectious Disease, Drug and Diagnostics Development, Epidemiology and Surveillance
Tuberculosis guidelines and best practices internationally Sarah Royce, MD, MPH Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Tuberculosis
HIV Transmission Cluster Analysis to Inform Prevention Hong-Ha Truong, PhD, MS, MPH Infectious Disease, HIV/AIDS, Neurology and Mental Health, Risk Reduction and Prevention
Snakebite treatment in Nepal Tommaso Bulfone, MS Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Mass Treatment of Soil-Transmitted Helminths as a Platform for National Cooperation and Action in Peru: Xochilt Borja, MS Zoonosis, Emerging Disease, and Drug Resistance, Health Economics and Effectiveness
he Efficacy of Various Antibiotics at Targeting Wolbachia for the Treatment of Lymphatic Filariasis Emma Gunderson, MS Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development, Pharmacology and Drug Treatment
Designing Selective Inhibitors of Calcium-Dependent Kinases in Parasites Kevan Shokat, PhD Zoonosis, Emerging Disease, and Drug Resistance
University of California Global Health Institute Program for Fellows and Scholars Craig Cohen, MD, MPH Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), HIV/AIDS, Opportunistic Infection, Tuberculosis, Malaria, Noncommunicable and/or Chronic Disease, Surgery and Anesthesia, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Diet, Exercise, and Obesity, Malnutrition, Micronutrients, Food Insecurity, Eye Disease and Blindness, Oral Health, Drug and Diagnostics Development, Immunology, Genetics, Pharmacology and Drug Treatment, Neurology and Mental Health, Dementia and Cognitive Impairment, Trauma and PTSD, Women's Health, Aging, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health, Adolescent Health, Health Economics and Effectiveness, Access or Barriers to Care, Immigration and Migration, Stigma and Discrimination, Smoking and Tobacco, Policy and Standards of Care, Systematic Reviews and Guideline Development, Epidemiology and Surveillance, Triangulation, Global Strategic Information, Implementation and Behavioral Science, Engagement in Care, Substance Abuse, Treatment Adherence, Health Systems Strengthening, Risk Reduction and Prevention, Residencies, Fellowships, and Postdoctoral Training
A point of care assay for chlamydia to assure prompt treatment in at risk minorities Julius Schachter, PhD Infectious Disease, Eye Disease and Blindness, Drug and Diagnostics Development
Fellowship - Award - 2016-2017 Pathogenesis and Treatment of Ebola-Associated Uveitis Rationale Nisha Acharya, MD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness
YV25718: A phase IIIb parallel group, open label study of pegylated interferon alfa-2a monotherapy (PEG-IFN, Ro 25-8310) compared to untreated control in children with HBeAg positive chronic hepatitis B Infectious Disease, Pediatrics
Identification of Signaling Pathways Associated with Lyme Disease Charles Chiu, MD, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Novel approaches to identify host genes required for Chlamydia pathogenesis Joanne Engel, MD, PhD Infectious Disease, Sexually Transmitted Infections (STIs), Drug and Diagnostics Development
HARC Center: HIV Accessory and Regulatory Complexes Alan Frankel, PhD Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Immunology
Biology of Infectious Diseases Training Program Henry Chambers, MD Infectious Disease, Residencies, Fellowships, and Postdoctoral Training
Sustained Strengthening of Public Health Laboratory, Transfusion Services and Health Care Worker Infection Control Practices for Ebola Virus Disease in Liberia Kayla Enriquez, MD, MPH Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Transfusion Medicine, Drug and Diagnostics Development, Policy and Standards of Care, Systematic Reviews and Guideline Development, Health Systems Strengthening, Training International Scholars and Clinicians
UZ-UCSF CTU Spilhaus Clinical Research Site HPTN 076 2nd Protocol Funding Zvavahera Chirenje, MD, FRCOG Infectious Disease, HIV/AIDS, Drug and Diagnostics Development, Women's Health, Training International Scholars and Clinicians, Patient and Peer Education
Interaction between Innate and Th2 Lymphocytes in Helminth Immunity Jesse Nussbaum, MD Zoonosis, Emerging Disease, and Drug Resistance
Natural History of HPV in Teens-Infection to Neoplasia Sexually Transmitted Infections (STIs), Cancer/Oncology, Adolescent Health
Academic Consortium Combating Ebola in Liberia Kayla Enriquez, MD, MPH Infectious Disease, Health Systems Strengthening, Training International Scholars and Clinicians
Fighting Infections through Research, Science and Technology (FIRST) Phase 1 and 2: Creating a Partnership to Fight Neglected Infectious Disease in Mesoamerica Jaime Sepulveda, MD, DSc, MPH Neglected Tropical Diseases (NTDs), Health Systems Strengthening
Reducing Health Disparities in Unintended Pregnancies Among Hispanic Adolescents Using a Patient-Centered Computer-Based Clinic Intervention Sexually Transmitted Infections (STIs), Family Planning, Adolescent Health
Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) - Domestic Sites - PHASE 2 Edward Murphy, MD, MPH Infectious Disease, Transfusion Medicine, Epidemiology and Surveillance
Real-Time Unbiased Pathogen Detection in Febrile Illnesses by Nanopore Sequencing Charles Chiu, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Merck Men's Efficacy Study, V501 Joel Palefsky, MD Infectious Disease
Pathogen discovery and epidemiology in tick vectors associated with Lyme-like diseases Charles Chiu, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance
A Two-Part, Open-Label, Single-Arm Phase 1/2 Study of Safety, Pharmacokinetics, and Efficacy of Telaprevir in Combination with Peginterferon alfa-2b and Ribavirin in Pediatric Subjects Aged 3 to 17 Infected With Genotype 1 Hepatitis C Virus Infectious Disease, HIV/AIDS, Pharmacology and Drug Treatment, Pediatrics
A Randomized, Double Blinded, Active-Controlled Study of Cb-183,315 in Patients with Clostridium-difficile-Associated Diarrhea Infectious Disease, Drug and Diagnostics Development
New approaches to study Pseudomonas-host interactions Joanne Engel, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance
The PIP2-Virus Interface and PI 4-Kinase: Novel Biology and Validation Targets Kevan Shokat, PhD Zoonosis, Emerging Disease, and Drug Resistance
NTD (Neglected Tropical Diseases) Modelling Consortium Thomas Lietman, MD Neglected Tropical Diseases (NTDs), Epidemiology and Surveillance
Global Fund Prospective Country Evaluations George Rutherford, MD Infectious Disease, Tuberculosis, Malaria, Women's Health, Pediatrics
Vertical Transmission of Zika Virus: Histopathological Investigations at the Maternal- Fetal Interface Stephanie Valderramos, MD, PhD Infectious Disease, Drug and Diagnostics Development, Immunology
GS-US-248-0122: A Long Term Follow-up Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Gilead-Sponsored Trials in Subjects with Chronic Hepatitis C Infection Mandana Khalili, MD Infectious Disease
Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Subjects with Chronic Hepatitis C Anne Luetkemeyer, MD Sexually Transmitted Infections (STIs)
Chemical Methods for Ferrous Iron Dependent Drug Delivery Adam Renslo, PhD Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development
Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Subjects with Chronic Hepatitis C Anne Luetkemeyer, MD Sexually Transmitted Infections (STIs)
Cambodia Integrated HIV and Drug Prevention Implementation Ellen Stein, MPH Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health, Implementation and Behavioral Science, Engagement in Care, Treatment Adherence
AI452-020-0092: Phase 3 Blinded Randomized Study of Peginterferon Lambda-1a and Ribavirin Compared to Peginterferon Alfa-2a and Ribavirin, Each Administered with Telaprevir in Subjects with Genotype-1 Chronic Hepatitis C who are Treatment-naïve or Re Mandana Khalili, MD Infectious Disease, Pharmacology and Drug Treatment
Disrupting Vector-Borne Disease Transmission in Complex Urban Environments Caryn Bern, MD, MPH Neglected Tropical Diseases (NTDs), Epidemiology and Surveillance
Profiling of Collaborator's Small Molecule Anti-filarials Judy Sakanari, PhD Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
A Phase 2, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Ledipasvir/Sofosbuvir in Subjects with Genotype 1, 4, 5 and 6 Chronic HCV Infection Who are on Dialysis for End Stage Renal Disease Mandana Khalili, MD Infectious Disease
HIV, HCV, and gender effects on Liver, Bone, and Vascular Health Phyllis Tien, MD Infectious Disease, HIV/AIDS
Predicting Progression of Human Prion Disease Michael Geschwind, MD, PhD Infectious Disease, Neurology and Mental Health
Bartonella: dissecting niche-specific adaptation in a human pathogen Zoonosis, Emerging Disease, and Drug Resistance
Vertical Transmission of Zika Virus: Placental Histopathology and Fetal Outcomes Stephanie Valderramos, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Neurology and Mental Health, Newborn and Infant Health
BSL3 upgrading for Live-attenuated poliovirus testing Raul Andino-Pavlovsky, PhD Infectious Disease, Immunology
Phase 1 Train of Na-APR-w and Na-GST-1 Hookworm Vaccine in Brazilian Adults Bryan Greenhouse, MD Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
California Department of Public Health (CDPH) Immunization Branch Contract George Rutherford, MD Infectious Disease, Engagement in Care, Risk Reduction and Prevention
Mentoring Multidisciplinary Patient-Oriented Research in Viral Hepatitis Mandana Khalili, MD Sexually Transmitted Infections (STIs)
Novel Mechanisms of Beta-lactam Resistance in Staph Aureus, Continuation A120553 Henry Chambers, MD Zoonosis, Emerging Disease, and Drug Resistance
Prevalence of and Behaviors Associated with Chlamydia Trachomatis Sexually Transmitted Infections among Females in Suva, Fiji Ginny Svigals, MS Sexually Transmitted Infections (STIs)
Drug-Resistant Tuberculosis on the Texas-Mexico Border: Improving the Quality of bi-national TB Projects Camila Hurtado, MS Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis
Understanding the Effects of Snake Envenomation in Livestock on the Lives of Farmers in the Southern Pacific Region of Costa Rica Andrea Nickerson, MS Zoonosis, Emerging Disease, and Drug Resistance
Whole Genome Sequence Characterization of Drug Resistant Malarial Strains Sumayya Mohammed, MS Zoonosis, Emerging Disease, and Drug Resistance, Malaria, Genetics
Community Perceptions of Intestinal Infections in the Sorsogon Province, the Philippines Ekaterina Tangog , MS Zoonosis, Emerging Disease, and Drug Resistance
Sepsis and the Developing World: An Assessment of Barriers and Facilitators to Sepsis Care in Tanzania Aleksandra Degtyar, MS Infectious Disease, Health Systems Strengthening, Risk Reduction and Prevention, Training and Capacity Building, Training International Scholars and Clinicians
Attitudes and Perceptions of a Musical Intervention "Iculo Ngenyoka" for Snakebite Awareness in Swaziland: A Qualitative Study Liam Erickson, MS Zoonosis, Emerging Disease, and Drug Resistance, Patient and Peer Education
A cognitive behavioral and structural HIV prevention intervention for young Ugandan women engaging in high risk sexual behavior Rachel King, PhD, MPH Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health, Implementation and Behavioral Science, Risk Reduction and Prevention
Natural History, Immunity, and Transmission Patterns of Sapovirus in a Nicaraguan Birth Cohort Caryn Bern, MD, MPH Infectious Disease, Epidemiology and Surveillance
Village Integrated Eye Workers Trial Thomas Lietman, MD Infectious Disease, Eye Disease and Blindness, Risk Reduction and Prevention
Quantitative bias analysis to adjust for misclassified pediatric diarrhea in a cluster-randomized trial Kristen Aiemjoy, MSc Neglected Tropical Diseases (NTDs), Pediatrics
The Impact of WASH on Re-infection with STH Jeremy Keenan, MD, MPH Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Epidemiology and Surveillance, Risk Reduction and Prevention
Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) - Central Laboratory Mark Seielstad, PhD HIV/AIDS, Infectious Disease, Transfusion Medicine, Epidemiology and Surveillance
Hepatitis C Therapeutic Registry and Research Network (HCV-TARGET) Infectious Disease, Cancer/Oncology
Fetal Zika virus infection: role of the human placenta Lenore Pereira, PhD Infectious Disease
Berkeley's Minority Health/Global Health Training Program Philip J. Rosenthal, MD Neglected Tropical Diseases (NTDs), HIV/AIDS, Malaria, Residencies, Fellowships, and Postdoctoral Training
P-S RPB - Assessing Corneal Ulcer Prevention with a Community-Randomized Trial Thomas Lietman, MD Neglected Tropical Diseases (NTDs), Eye Disease and Blindness, Pharmacology and Drug Treatment
A Patient-Centered Intervention to Increase Screening of Hepatitis B and C among Asian Americans Tung Nguyen, MD Infectious Disease
California Emerging Infections Program Ina Park, MD Zoonosis, Emerging Disease, and Drug Resistance, Epidemiology and Surveillance, Health Systems Strengthening, UCSF Professional Education
Predictors of Cardiomyopathy Progression in a Cohort of Bolivian Patients with Chagas Disease Caryn Bern, MD, MPH Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Cardiovascular Disease
The impact of antimalarial resistance on malaria transmission in Uganda Melissa Conrad, PhD Zoonosis, Emerging Disease, and Drug Resistance, Malaria
Thai Red Cross S&S, HPV TA008 Joel Palefsky, MD Infectious Disease, Sexually Transmitted Infections (STIs), Cancer/Oncology, Pharmacology and Drug Treatment
Integrative Pharmacology Approach to Understand Mechanisms of Tuberculosis Drug Resistance Rada Savic, PhD Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development
Fetal HCMV Infection: Role of the Human Placenta Lenore Pereira, PhD Infectious Disease, Women's Health, Newborn and Infant Health
Metagenomic Contributions to Type 2 Diabetes Among Filipino Populations Mark Seielstad, PhD Transfusion Medicine, Diabetes, Genetics, Epidemiology and Surveillance
De Facto Monotherapy during Multidrug Tuberculosis Treatment and Emergence of Resistance Rada Savic, PhD Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis
Advancing Broad Spectrum Host-Targeting Antiviral Strategies to the Clinic Kevan Shokat, PhD Zoonosis, Emerging Disease, and Drug Resistance
STI Screening as a Combined HIV Prevention Platform for MSM in Peru James Dilley, MD Sexually Transmitted Infections (STIs), HIV/AIDS, Epidemiology and Surveillance, Implementation and Behavioral Science, Engagement in Care
Age of Blood in Children in Pediatric Intensive Care Units Transfusion Medicine, Pediatrics
Host-Directed Strategies to Create Synergistic Antibacterial Therapies Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development, Immunology
Naturally acquired immunity to norovirus in a newborn cohort in Peru Caryn Bern, MD, MPH Infectious Disease, Immunology, Newborn and Infant Health
The Microbiome, Virome and Host Response in Ventilator Associated Pneumonia Joseph Derisi, PhD Infectious Disease, Opportunistic Infection
Prevalence of baseline and longitudinal heteroresistant M. tuberculosis and association with patient-important outcomes John Metcalfe, MD Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis
(PQ5) Role of HIV-associated cellular miRNAs in HPV 16-induced pathogenesis Joel Palefsky, MD Infectious Disease, Sexually Transmitted Infections (STIs), Cancer/Oncology
GS-US-367-1172: A Phase 3, Global, Multicenter, Randomized, Open-Label Study to Investigate the Safety and Efficacy of Sofosbuvir/Velpatasvir/GS-9857 Fixed-Dose Combination for 8 Weeks Compared to Sofosbuvir/Velpatasvir for 12 Weeks in Direct-Acting Mandana Khalili, MD Infectious Disease, Pharmacology and Drug Treatment
Trefoil Factor Proteins Modulate Host Immunity against Hookworms Zoonosis, Emerging Disease, and Drug Resistance, Immunology
Pegylated Interferon Lambda w/wo Daclatasvir, Compared to Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C Genotype 2 and 3 Mandana Khalili, MD Sexually Transmitted Infections (STIs)
HIV, HCV, and gender effects on Liver, Bone, and Vascular Health Phyllis Tien, MD Infectious Disease, HIV/AIDS, Residencies, Fellowships, and Postdoctoral Training
Real-Time Detection of Bloodborne Pathogens by Unbiased Nanopore Sequencing 20150506 Charles Chiu, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Translational Approaches to Develop Drug Therapy for Diarrhea Alan Verkman, MD, PhD Infectious Disease, Pediatrics
UCSF RPB Unrestricted Grant Application Stephen Mcleod, MD Infectious Disease, Eye Disease and Blindness
Trainings for HIV and HCV testing and prevention James Dilley, MD Infectious Disease, HIV/AIDS, Training and Capacity Building
Impact of HIV PMTCT Interventions on HBV Disease in n HIV/HBV Co-infected Women and their Infants Marion Peters, MD Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health
Natural History of HPV in Teens-Infection to Neoplasia Sexually Transmitted Infections (STIs), Cancer/Oncology, Adolescent Health
Infectious disease laboratories George Rutherford, MD Infectious Disease, Tuberculosis
Novel methods for monitoring long-term drug exposure and resistance amplification during treatment of multidrug resistant tuberculosis John Metcalfe, MD Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development
Naturally acquired immunity to norovirus in a newborn cohort in Peru Caryn Bern, MD, MPH Zoonosis, Emerging Disease, and Drug Resistance, Newborn and Infant Health
Next Generation of HPV and Cervical Cancer Research in HIV+ Women Joel Palefsky, MD HIV/AIDS, Infectious Disease, Sexually Transmitted Infections (STIs), Cancer/Oncology
Identifying Opportunities to Increase Syphilis Partner Services Uptake and Improve Outcome Measures, San Francisco - Phase II Kim Koester, PhD Sexually Transmitted Infections (STIs), Engagement in Care
Mentoring Multidisciplinary Patient-Oriented Research in Viral Hepatitis Mandana Khalili, MD Infectious Disease, Residencies, Fellowships, and Postdoctoral Training
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naive Subjects with Chronic HCV GT1, GT4, GT5, and GT6 Infection who are on Opiate Substitution Therapy Anne Luetkemeyer, MD Infectious Disease, HIV/AIDS, Pharmacology and Drug Treatment
Acute Hepatitis C Infection in Young Injectors (incoming sub) Judith Hahn, PhD, MD Infectious Disease, Substance Abuse
Chagas Caryn Bern, MD, MPH Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
HBV/HIV Co-Infection Research Network Mandana Khalili, MD Sexually Transmitted Infections (STIs), HIV/AIDS
International Traineeships in AIDS Prevention Studies (ITAPS) George Rutherford, MD Infectious Disease, HIV/AIDS, Residencies, Fellowships, and Postdoctoral Training
Sanitation, Water, and Instruction in Face-washing for Trachoma (SWIFT) Jeremy Keenan, MD, MPH Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness
Effectiveness of Simulation-Based Training to Prevent and Manage Postpartum Hemorrhage in Low and Middle-Income Countries: A Systematic Review and Meta-Analysis Ria Saha, MS Infectious Disease, Pediatrics
Interventions to Improve Non-Malarial Fever Diagnosis in Mobile Health Clinics in Mulanje, Malawi Fiona Sylvies, MS Infectious Disease, Drug and Diagnostics Development
Infection Control Training Program: Hand Hygiene in Roatán, Honduras Alexis Stanley, MS Infectious Disease, Risk Reduction and Prevention
Selective AAK1 and GAK inhibitors for combating Dengue and other emerging viral infections Raul Andino-Pavlovsky, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Immunology